University of Southern California

Research

COVID-19 Research Funding

Last Updated: July 2, 2020

Jump to:

COVID-19 Federal Funding
COVID-19 Non-Federal Funding
COVID-19 USC Internal Funding

 

COVID-19 Federal Funding

GrantForward has provided free access to a list of funding opportunities in the area of COVID-19 that will be updated on a daily basis at Grant COVID.

White House

3/23 – Researchers are invited to submit COVID-19 related research proposals to the COVID-19 High Performance Computing Consortium via the online portal which will then be reviewed and matched with computing resources from one of the partner institutions. An expert panel of top scientists and computing researchers will work with proposers to quickly assess the public health benefit of the work and coordinate the allocation of the group’s powerful computing assets. Learn more at White House Announces New Partnership to Unleash U.S. Supercomputing Resources to Fight COVID-19. Deadline: Rolling.

Biomedical Advanced Research and Development Authority (BARDA)

4/02 – BARDA Broad Agency Announcement (BAA) has issued amendment 15. Learn more at Research and Development in Biotechnology. Deadline: October 31, 2020.

Department of Commerce (DOC)

3/30 – National Institute of Standards and Technology (NIST) invites Manufacturing USA institutes to propose high-impact projects designed to respond to the COVID-19 pandemic. Learn more at NIST Manufacturing USA National Emergency Assistance Program. Deadline: Rolling.

Department of Education (ED)

4/30 – Department of Education has posted the CARES Act – Higher Education Emergency Relief Fund Funding opportunity for FIPSE (84.425N) program. Learn more at ED-GRANTS-043020-005. Deadline: Aug 1, 2020.

Department of Energy (DOE)

3/17 – The U.S. Department of Energy (DOE) encourages you to consider scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure. Learn more at DOE Seeking Input and Collaboration on Science and Technology Response to COVID-19. Deadline: Rolling.

Health and Human Services (HHS)

4/23 – National Center for Advancing Translational Sciences (NCATS) is soliciting applications for Administrative Supplements (through PA-18-591) and Emergency Competitive Revisions (through PA-20-135). Learn more at NOT-TR-20-028. Deadline: Rolling until November 10, 2020.

3/06 – Department of Health and Human Services (HHS) has updated a broad agency announcement (BAA) to focus specifically on products to diagnose, prevent or treat coronavirus infections. Learn more at HHS Solicits Proposals for Development of Medical Products for Novel Coronavirus. Deadline: October 31, 2020.

Intelligence Advanced Research Projects Activity (IARPA)

5/21 – The  Intelligence  Advanced  Research  Projects  Activity  (IARPA) invests  in  high-risk/high-payoff  research  programs  that  have  the potential  to  provide  our  nation with  an overwhelming intelligence  advantage.  The  current  COVID-19  pandemic  focuses  attention  on the  need  for technologies to assist with: detection and sensing; supply chain management and integrity; geo-spatio-temporal monitoring and mapping, with privacy protection; information reliability and collaboration tools; and modeling, simulation, and predictive analytics. Learn more at IARPA-BAA-20-01. Deadline: July 07, 2020.

National Institutes of Health (NIH)

6/26 – NIH has issued a notice to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations. Learn more at PAR-20-243. Deadline: August 20, 2020, December 2, 2020, March 2, 2021.

6/26 – NIH has issued a notice to stimulate research to test causal mechanisms underlying the etiology or prevention of dental fear, anxiety, or phobia. Including: Processes unique to special groups, populations, or circumstances including pediatric populations, racial/ethnic minority groups, individuals with special needs, fear or anxiety related to COVID-19, etc. Learn more at RFA-DE-21-001. Deadline: October 10, 2020.

6/25 – Leidos Biomedical Research, Inc. (Leidos Biomed) has issued an RFP for Capacity Building Centers to support the Serological Sciences Network (SeroNet), developed to mobilize collaborative efforts to develop serological assays of high specificity and high sensitivity for deployment to test for SARS-CoV-2 induced immune responses and to rapidly expand national serological testing capacity. Learn more at NOT-CA-20-077.

6/25 – NIH has issued a notice to highlight the urgent need for research on COVID-19 in individuals with Down syndrome in conjunction with the INCLUDE Project. The overarching goal of this NOSI is to improve understanding and treatment of COVID-19 infection in individuals with Down syndrome and reduce COVID-19 associated morbidity and mortality for this population, which may be disproportionately affected by, have higher infection rates of, and/or be at elevated risk for adverse outcomes from contracting the virus. Learn more at NOT-OD-20-129.

6/17 – NIH has issued a notice encouraging applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups. Learn more at PAR-20-237. Deadline: August 28, 2020; December 1, 2020.

6/15 – NIH has issued a notice inviting applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity, mortality, severity, or complications of Coronavirus Disease 2019 (COVID-19). Learn more at PAR-20-234. Deadline: August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; and February 1, 2021.

6/15 – The National Center for Advancing Translational Sciences (NCATS) has issued a notice for Administrative Supplements (through PA-18-591) from current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients. Learn more at NOT-TR-20-029.

6/12 – NIH has issued a notice for the Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) initiative, a consortium of community-engaged research projects to understand factors that have led to disproportionate burden of the pandemic on the underserved and/or vulnerable populations so that interventions can be implemented to decrease these disparities. This FOA seeks to fund a single Coordination and Data Collection Center (CDCC) as an integral part of the consortium. Learn more at RFA-OD-20-013. Deadline: July 8, 2020.

6/12 – NIH has issued a limited competition notice to highlight the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. Learn more at NOT-OD-20-121. Deadline: August 07, 2020.

6/12 – NIH has issued a notice to highlight the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. Learn more at NOT-OD-20-120. Deadline: July 8, 2020.

6/12 – NIH has issued a notice to highlight the urgent need to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing among underserved and/or vulnerable populations across the United States through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. Learn more at NOT-OD-20-119. Deadline: July 8, 2020.

6/05 – National Cancer Institute has posted a funding opportunity to develop, validate, improve, and implement serological testing and associated technologies. Learn more at RFA-CA-20-039. Deadline: July 22, 2020.

6/05 – National Cancer Institute has posted a funding opportunity to establish Serological Sciences Centers of Excellence with the goal to develop, validate, improve, and implement serological testing and associated technologies. Learn more at RFA-CA-20-038. Deadline: July 22, 2020.

6/04 – The National Institute of Mental Health (NIMH) with other ICs are issuing this Notice of Intent to Publish a Funding Opportunity Announcement to promote new initiatives that will solicit applications to support research to determine the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), wearable devices] to address secondary health effects of the social, behavioral, and economic changes following the COVID-19 pandemic, particularly among populations who experience health disparities and vulnerable populations. Learn more at NOT-MH-20-058. Deadline: July 20, 2020.

6/04 – National Institute on Deafness and Other Communication Disorders (NIDCD) has posted a notice supporting research on the impact of COVID-19 on mission specific sensory and communication disorders. Learn more at NOT-DC-20-008. Deadline: October 05, 2020.

6/03 – The National Institute of Minority Health and Health Disparities (NIMHD) intends to promote a new initiative to solicit research to evaluate community interventions testing. Learn more at NOT-MD-20-023. Deadline: July 22, 2020.

5/26 – The National Center for Complementary and Integrative Health (NCCIH) announces the availability of funds for Administrative Supplements or Urgent Competitive Revisions to promote research on the effects of natural products alone or in combination with other complementary and integrative health approaches on COVID-19. Learn more at NOT-AT-20-012. Deadline: August 18, 2020.

5/21 – The NIH Director’s Early Independence Award supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training. Due to the COVID-19 public health emergency, the Common Fund will dedicate funds provided by the CARES Act to support a total of 5-10 Early Independence Awards (through this FOA) or Transformative Research Awards (through RFA-RM-20-020) that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Learn more at RFA-RM-20-021. Deadline: September 4, 2020.

5/15 – National Cancer Institute (NCI) intends to publish on June 10 a FOA to develop, validate, improve, and implement serological testing and associated technologies. Learn more at NOT-CA-20-066. Deadline: July 20, 2020.

5/07 – The purpose of this Notice is to add a “third due date” and additional “areas of focus especially of interest” for PAR-19-373 and PAR-19-384 “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed/Basic Experimental Studies with Humans Required). Learn more at NOT-OD-20-103. Deadline: March 17, 2021.

5/05 – National Institute of Dental and Craniofacial Research (NIDCR) has issued a notice to highlight the urgent need for research on topics that would be of immediate and high impact to protect and ensure the safety of personnel and patients in dental practices, prevent SARS-CoV-2 transmission, and improve detection and diagnosis of COVID-19. Successful X01 applicants will be given access to the National Dental PBRN infrastructure to support an individual project. Learn more at NOT-DE-20-023. Deadline: November 2, 2020.

5/05 – National Institute of Dental and Craniofacial Research (NIDCR) has issued a notice to highlight the urgent need for research on topics that would be of immediate and high impact to protect and ensure the safety of personnel and patients in dental practices. Learn more at NOT-DE-20-022. Deadline: November 2, 2020.

4/30 – NINDS has issued a notice to highlight the urgent need for research on COVID-19 and on biological effects on the nervous system of its causative agent, SARS-CoV-2. Research of interest must fall within NINDS’s scientific mission, which is to support basic, translational, and clinical neuroscience research to expand fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. Learn more at NOT-NS-20-051. Deadline: April 15, 2021.

4/30 – NIAID has issued a FOA to improve understanding of fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures and to share findings quickly and broadly for COVID-19. R21 Clinical Trial Not Allowed. Learn more at PAR-20-177. Deadline: Rolling.

4/30 – NIAID has issued a FOA to improve understanding of fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures and to share findings quickly and broadly for COVID-19. R01 Clinical Trial Not Allowed. Learn more at PAR-20-178. Deadline: Rolling.

4/29 – The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Learn more at Rapid Acceleration of Diagnostics (RADx). Deadline: Rolling.

4/27 – National Heart, Lung, and Blood Institute (NHLBI) has issued a notice due to the urgent need for early phase clinical trials to evaluate new or existing interventions that may prevent or treat COVID-19. NHLBI seeks to leverage existing clinical trials expertise and, using NHLBI programs that are actively conducting Phase I-III clinical trials, to rapidly initiate and conduct Phase I-Phase I/II (bridging) clinical trials in patients at risk for SARS-CoV-2 infection and/or patients with COVID-19. Learn more at NOT-HL-20-782. Deadline: October 6, 2020.

4/16 -National Institute on Alcohol Abuse and Alcoholism (NIAAA) has issued a notice to understand the potentially complex relationships between alcohol consumption and COVID-19 related-outcomes to enhance the nation’s response to the current pandemic. Learn more at NOT-AA-20-011. Deadline: April 16, 2021.

4/13 – This Notice of Special Interest (NOSI) highlights the urgent need for social, behavioral, economic, health communication, and epidemiologic research relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19. Learn more at NOT-OD-20-097. Deadline: Rolling through March 31, 2021.

4/10 – The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19). The NIBIB is seeking applications to develop life-saving technologies that can be ready for commercialization within one to two years. Learn more at NOT-EB-20-006. Deadline: March 31, 2021.

4/10 – National Center for Complementary and Integrative Health (NCCIH) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). Topics of specific interest for this NOSI include research on stress management strategies, including mind and body approaches, that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections. Learn more at NOT-AT-20-011. Deadline: Rolling until October 6, 2020.

4/10 – National Institute of Biomedical Imaging and Bioengineering (NIBIB) has posted NOT-EB-20-007 and NOT-EB-20-008 to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19). Deadline: November 10, 2020, and March 31, 2021.

4/09 – National Institute of Environmental Health Sciences (NIEHS) is issuing this Notice of Special Interest (NOSI) to address the urgent need for mission-relevant research to understand the impact of environmental exposures on Coronavirus Disease 2019 (COVID-19) and its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). Learn more at NOT-ES-20-015. Deadline: May 4, 2021.

4/09 – National Institute on Minority Health and Health Disparities (NIMHD) has issued a notice to highlight the urgent need for research on the impact of the novel Coronavirus (SARS-CoV-2) pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations. Learn more at NOT-MD-20-019. Deadline: May 1, 2021.

4/09 – National Institute of Mental Health (NIMH) has issued a notice to highlight interest in research to strengthen the mental health response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. Learn more at NOT-MH-20-047. Deadline: April 16, 2021.

4/09 – National Center for Advancing Translational Sciences (NCATS) has posted NOT-TR-20-016 and NOT-TR-20-017 to highlight the urgent need for research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and advance the translation of research findings into diagnostics, therapeutics, and vaccines. Deadline: January 26, 2022.

4/02 – In order to rapidly improve understanding and available control measures for 2019-nCoV, National Institute on Aging (NIA) is encouraging the submission of applications for either Administrative Supplements (PA-18-591) or Competitive Revisions (PA-18-935) to active grants to address research areas of interest. Learn more at NOT-AG-20-022. Deadline: May 1, 2021.

3/27 – National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes, i.e., “coronavirus disease 2019” (COVID-19). NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial. Learn more at NOT-TR-20-012. Deadline: October 17, 2020.

3/27 – National Institute of Allergy and Infectious Diseases (NIAID) is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. Learn more at NOT-AI-20-031. Deadline: April 5, 2021.

3/25 – National Institute of General Medical Sciences (NIGMS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19). Learn more at NOT-GM-20-025. Deadline: February 6, 2021.

3/25 – National Institute of Allergy and Infectious Diseases (NIAID) is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. Learn more at NOT-AI-20-034. Deadline: March 25, 2021.

3/24 – National Center for Advancing Translational Sciences (NCATS) has issued this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (COVID-19). NCATS is particularly interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. Learn more at NOT-TR-20-011. Deadline: July 10, 2021.

3/19 – NIH has issued a notice to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). National Institute on Drug Abuse (NIDA) is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. Learn more at NOT-DA-20-047. Deadline: March 31, 2021.

National Science Foundation (NSF)

5/05 – This annual multi-agency Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and social drivers that influence the transmission dynamics of infectious diseases. Learn more at NSF 19-592. Deadline: November 18, 2020.

4/17 – NSF has issued a letter to researchers inviting proposals for rapid response research grants related to the virus. The letter welcomes studies to help understand COVID-19, inform and educate the public about virus transmission and prevention, and develop effective strategies for addressing this challenge at the local, state and national levels. Learn more at NSF 20-052. Deadline: Rolling.

4/16 – The participating NIH institutes on this solicitation are interested in supporting the development of CPS research and technology to facilitate medical treatment during a national crisis (e.g. SARS-CoV-2); achieve functional independence in humans; improve quality of life; assist with behavioral therapy and personalized care; monitor or generate accurate readouts of therapeutic effects of therapies; prevent disease and disability; and promote wellness/health. Learn more at NSF 20-563. Deadline: December 2, 2020.

Office of Science and Technology Policy

3/16 – In response to the COVID-19 pandemic, the Allen Institute for AI has partnered with leading research groups to prepare and distribute the COVID-19 Open Research Dataset (CORD-19), a free resource of over 29,000 scholarly articles, including over 13,000 with full text, about COVID-19 and the coronavirus family of viruses for use by the global research community. The White House has issued a call to action to the Nation’s artificial intelligence experts to develop new text and data mining techniques that can help the science community answer high-priority scientific questions related to COVID-19. Learn more at Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset. Deadline: Rolling.

 Back to Top

 

COVID-19 Non-Federal Funding

GrantForward has provided free access to a list of funding opportunities in the area of COVID-19 that will be updated on a daily basis at Grant COVID.

American Lung Association

4/20 – The American Lung Association is launching a $25M initiative to end COVID-19 and defend against future respiratory virus pandemics. Learn more at COVID-19 Action Initiative. Deadline: Rolling.

Autism Science Foundation

4/29 – Autism Science Foundation invites applications for its new COVID-19 Pivot Grant Program. This funding is intended to help researchers manage changes in research projects due to the COVID-19 emergency. The current RFA is limited to scientists early in their career with an established university or research institution affiliation. Learn more at COVID-19 Pivot Grant. Deadline: July 15, 2020.

California Breast Cancer Research Program (CBCRP)

4/06 – In light of the emergence and spread of COVID-19 in California and beyond, the statewide funding programs of the University of California Office of the President (UCOP) Research Grants Program Office (California Breast Cancer Research Program (CBCRP), Tobacco-Related Disease Research Program (TRDRP), California HIV/AIDS Research Program (CHRP)) and the Type 1 Diabetes Research Fund are together making available up to $2M to immediately support urgent research to mitigate the pandemic. Learn more at Emergency COVID-19 Research Seed Funding. Deadline: Rolling.

Coalition for Epidemic Preparedness Innovations (CEPI)

2/14 – CEPI issues calls for proposals and requests for information inviting applicants to submit proposals for projects to develop vaccine candidates and support clinical trials involving vaccine candidates. Learn more at Call for Proposals. Deadline: Rolling.

Data.org

5/19 – As part of our commitment to building the field of data science for social impact, data.org launched a $10 million data.org Inclusive Growth and Recovery Challenge. The challenge is an open call for breakthrough ideas that harness the power of data science to help people and communities thrive especially in the wake of COVID-19’s economic impact. Learn more at Data.org Inclusive Growth and Recovery Challenge. Deadline: July 17, 2020.

Ferring Pharmaceuticals

4/09 – Ferring is interested in funding exploratory, basic, and clinical research grants to collect data and expand knowledge about the effects on SARS-CoV-2 on reproduction, pregnancy, and foetal/neonatal health. Learn more at Reproductive Medicine and Maternal Health. Deadline: Rolling until October 31, 2020.

Gilead Medical Affairs

6/30 – In an effort to further address the unmet medical need in COVID-19, Gilead Medical Affairs is launching the COMMIT program. The COMMIT program will support well defined individual projects of no more than $250,000 USD or equivalent sum; projects that are more than $250,000 will require approval by Gilead prior to submission. Learn more at COVID-19 RFP Program: COMMIT. Deadline: Aug 3, 2020.

Ginkgo Bioworks

3/17 – Ginkgo is now offering $25M of no-cost foundry work towards projects that can use Ginkgo’s platform to accelerate development of point of care diagnostics, vaccines, or therapeutics. Learn more at ginkgobioworks.com. Deadline: Rolling.

IBM

3/27 – The 2020 Call for Code Global Challenge has expanded its focus to tackle the effects of COVID-19. Technology solutions can help reduce the impact this pandemic has on our daily lives and the world. We have the tools. You have the talent. Learn more at COVID-19: Fight the Global Pandemic. Deadline: July 31, 2020.

Mozilla

3/31 – Mozilla has announced the creation of a COVID-19 Solutions Fund as part of the Mozilla Open Source Support Program (MOSS). Through this fund, we will provide awards of up to $50,000 USD each to open source technology projects which are responding to the COVID-19 pandemic in some way. Learn more at Mozilla Open Source Support Awards. Deadline: Rolling.

Robert Wood Johnson Foundation

4/15 – The foundation is interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Learn more at Pioneering Ideas: Exploring the Future to Build a Culture of Health. Deadline: Rolling.

Russell Sage Foundation (RSF)

6/30 – RSF has long supported social science research with the aim of improving social and living conditions in the United States.  The severe consequences of the Covid19-pandemic, including its economic disruptions, and the recent mass protests to combat systemic racial inequality in policing and other institutions have reaffirmed the importance of social science research examining economic, political, racial, ethnic, generational, and social inequalities relevant to public policy and social change. Learn more at Russell Sage Foundation. Deadline: August 5, 2020.

 Back to Top

 

COVID-19 USC Internal Funding

Keck School of Medicine

5/07 – Seeking promising ideas and approaches to understand and mitigate COVID-19 and its impact on individuals and society. Applicant may apply for one of the following research categories: Mechanistic or applied research at any level, from basic discovery to community and population health. Development of shareable COVID-19 research resources. Community education and engagement. Priority will be given to proposals with high potential for immediate impact. Learn more here and here. Deadline: July 22, 2020.

 Back to Top